Onesource Specialty Pharma Limited
ONESOURCE · General/Diversified · NSE
₹1,498
Current Market Price
Fair Value (DCF)
₹1,348
Margin of Safety
-10.0%
Updated just now
YieldIQ Score
42/100
Piotroski F-Score
5/9
Economic Moat
None
Confidence
25%
ROE
-30.6%
Debt/Equity
0.00
WACC
12.8%
Market Cap
₹0.17 Lakh Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
140.0%
Return on capital employed
EV / EBITDA
61.2×
Enterprise multiple
Debt / EBITDA
3.6×
Leverage vs earnings
Interest Coverage
0.6×
EBIT covers interest
Current Ratio
0.98×
Short-term liquidity
Asset Turnover
0.18×
Revenue per ₹ of assets
Revenue CAGR (3Y)
—
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹1,497.6
Bear case
₹115.74
MoS -1193.9%
Base case
₹1,347.84
MoS -11.1%
Bull case
₹1,448.93
MoS -3.4%
Ratio Trends
ONESOURCE · last 3 annual periods
ROE
-0.3%
ROCE
5.3%
Operating Margin
—
Debt / Equity
0.16×
PE
—
EV / EBITDA
—
Historical Financials
ONESOURCE · Annual, last 3 years· amounts in ₹Cr unless noted
| Metric | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|
| Revenue | ₹38.7 Cr | ₹172 Cr | ₹1445 Cr | +510.9% |
| EBITDA | ₹-261 Cr | ₹-185 Cr | ₹361 Cr | — |
| EBIT | — | — | — | — |
| PAT | ₹-800 Cr | ₹-391 Cr | ₹-18.0 Cr | — |
| EPS (diluted) | — | — | — | — |
| CFO | ₹-163 Cr | ₹-107 Cr | ₹-67.9 Cr | — |
| CapEx | ₹-44.0 Cr | ₹-63.8 Cr | ₹-128 Cr | — |
| FCF | ₹-207 Cr | ₹-171 Cr | ₹-196 Cr | — |
| Total Assets | ₹2009 Cr | ₹1309 Cr | ₹7550 Cr | +93.9% |
| Total Debt | ₹864 Cr | ₹571 Cr | ₹942 Cr | +4.4% |
| Shareholders' Equity | ₹785 Cr | ₹396 Cr | ₹5881 Cr | +173.6% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
ONESOURCE vs 3 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| CONCORDBIO CONCORDBIO | — | — | Pending | 20.5% | — |
| BLUEJET BLUEJET | — | — | Pending | 26.9% | — |
| SUPRIYA SUPRIYA | — | — | Pending | 18.9% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for ONESOURCE in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. Onesource Specialty Pharma Limited (ONESOURCE.NS) trades at 1497.60 vs a model fair value of 1347.84, a gap of -10.0%. Piotroski F-score:...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of ONESOURCE →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for ONESOURCE →
Compare
Head-to-head with peers
Compare ONESOURCE side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse ONESOURCENow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.